Huntington National Bank’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $381 | Hold |
1
| – | – | ﹤0.01% | 2464 |
|
|
2025
Q4 | $381 | Hold |
1
| – | – | ﹤0.01% | 2380 |
|
|
2025
Q3 | $381 | Hold |
1
| – | – | ﹤0.01% | 2439 |
|
|
2025
Q2 | $381 | Hold |
1
| – | – | ﹤0.01% | 2489 |
|
|
2025
Q1 | $381 | Hold |
1
| – | – | ﹤0.01% | 2510 |
|
|
2024
Q4 | $381 | Hold |
1
| – | – | ﹤0.01% | 2547 |
|
|
2024
Q3 | $381 | Hold |
1
| – | – | ﹤0.01% | 2533 |
|
|
2024
Q2 | $381 | Hold |
1
| – | – | ﹤0.01% | 2464 |
|
|
2024
Q1 | $381 | Hold |
1
| – | – | ﹤0.01% | 2375 |
|
|
2023
Q4 | $381 | Hold |
1
| – | – | ﹤0.01% | 2307 |
|
|
2023
Q3 | $381 | Hold |
1
| – | – | ﹤0.01% | 2282 |
|
|
2023
Q2 | $381 | Hold |
1
| – | – | ﹤0.01% | 2245 |
|
|
2023
Q1 | $381 | Hold |
1
| – | – | ﹤0.01% | 2100 |
|
|
2022
Q4 | $381 | Sell |
1
-17
| -94% | -$5.66K | ﹤0.01% | 1951 |
|
|
2022
Q3 | $4K | Hold |
18
| – | – | ﹤0.01% | 1775 |
|
|
2022
Q2 | $4K | Buy |
18
+14
| +350% | +$3.78K | ﹤0.01% | 1803 |
|
|
2022
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 2006 |
|
|
2021
Q4 | $1K | Buy |
4
+1
| +33% | +$338 | ﹤0.01% | 1983 |
|
|
2021
Q3 | $0 | Buy |
+3
| New | +$1.02K | ﹤0.01% | 2122 |
|
|
2020
Q1 | – | Sell |
-166
| Closed | -$28K | – | 1931 |
|
|
2019
Q4 | $28K | Buy |
166
+16
| +11% | +$2.97K | ﹤0.01% | 1136 |
|
|
2019
Q3 | $27K | Hold |
150
| – | – | ﹤0.01% | 1027 |
|
|
2019
Q2 | $39K | Hold |
150
| – | – | ﹤0.01% | 920 |
|
|
2019
Q1 | $43K | Hold |
150
| – | – | ﹤0.01% | 894 |
|
|
2018
Q4 | $49K | Sell |
150
-50
| -25% | -$17.4K | ﹤0.01% | 860 |
|
|
2018
Q3 | $90K | Hold |
200
| – | – | ﹤0.01% | 757 |
|
|
2018
Q2 | $82K | Sell |
200
-75
| -27% | -$27.2K | ﹤0.01% | 795 |
|
|
2018
Q1 | $80K | Sell |
275
-25
| -8% | -$6.34K | ﹤0.01% | 821 |
|
|
2017
Q4 | $56K | Hold |
300
| – | – | ﹤0.01% | 947 |
|
|
2017
Q3 | $51K | Sell |
300
-400
| -57% | -$60.5K | ﹤0.01% | 976 |
|
|
2017
Q2 | $100K | Buy |
+700
| New | +$94.1K | ﹤0.01% | 757 |
|
|
2016
Q2 | – | Sell |
-850
| Closed | -$61K | – | 1718 |
|
|
2016
Q1 | $61K | Buy |
850
+650
| +325% | +$54.9K | ﹤0.01% | 1052 |
|
|
2015
Q4 | $18K | Hold |
200
| – | – | ﹤0.01% | 1265 |
|
|
2015
Q3 | $19K | Hold |
200
| – | – | ﹤0.01% | 1288 |
|
|
2015
Q2 | $13K | Sell |
200
-650
| -76% | -$43.2K | ﹤0.01% | 1454 |
|
|
2015
Q1 | $61K | Sell |
850
-600
| -41% | -$32.6K | ﹤0.01% | 1057 |
|
|
2014
Q4 | $55K | Buy |
+1,450
| New | +$45.7K | ﹤0.01% | 1100 |
|
|
2014
Q1 | – | Sell |
-500
| Closed | -$13K | – | 1609 |
|
|
2013
Q4 | $13K | Buy |
+500
| New | +$12.4K | ﹤0.01% | 1405 |
|
Huntington National Bank's ABMD Position: Q1 2026 in Review
Huntington National Bank held its Abiomed Inc (ABMD) position steady in Q1 2026 at 1 share worth $381. The position accounts for ﹤0.01% of the portfolio, ranked #2464.
Huntington National Bank first reported a position in ABMD in Q4 2013 and has held it in 37 quarters since. The position peaked at $100K in Q2 2017. 1 fund tracked by Wall St. Rank holds ABMD as of Q1 2026.
- Huntington National Bank held 1 share of Abiomed Inc worth $381 as of Q1 2026.
- Huntington National Bank left its Abiomed Inc share count unchanged in Q1 2026.
- Abiomed Inc made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2464 holding.
- Huntington National Bank first reported a position in Abiomed Inc in Q4 2013 and has held it in 37 quarters since.
- Huntington National Bank's Abiomed Inc position peaked at $100K in Q2 2017.
- 1 fund tracked by Wall St. Rank held Abiomed Inc as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.